Clinical Trial Update: A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

View source ↗

Summary

This document describes a long-term follow-up study involving subjects who received CRISPR-based CAR T cell therapies; the trial is currently enrolling by invit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Drugs mentioned

• CRISPR CAR-T cell therapy (CRISPR CAR-T)

Snippet

Sponsor: CRISPR Therapeutics AG | Conditions: Hematologic Malignancy, Solid Malignancy | Status: ENROLLING_BY_INVITATION